Lista de obras -

A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer

artículo científico publicado en 2007

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

artículo científico publicado en 2017

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

artículo científico publicado en 2014

Clinical development of mTor inhibitors for renal cancer

artículo científico publicado en 2017

Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.

artículo científico publicado en 2017

Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials

artículo científico publicado en 2017

Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.

artículo científico publicado en 2010

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

artículo científico publicado en 2013

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis

artículo científico publicado en 2017

Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.

artículo científico publicado en 2006

Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity

artículo científico publicado en 2016

Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer

artículo científico publicado en 2017

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report

artículo científico publicado en 2007

Pituitary gland metastasis from rectal cancer: report of a case and literature review

artículo científico publicado en 2013

Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies

artículo científico publicado en 2017

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

artículo científico publicado en 2014

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer

artículo científico publicado en 2016

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II tr

artículo científico publicado en 2010

Targeted therapies in gastric cancer treatment: where we are and where we are going.

artículo científico publicado en 2016

Lista de obras de

A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

Clinical development of mTor inhibitors for renal cancer

Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.

Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials

Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis

Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.

Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity

Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report

Pituitary gland metastasis from rectal cancer: report of a case and literature review

Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis

Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial.

Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II tr

Targeted therapies in gastric cancer treatment: where we are and where we are going.